整合型多组学研究揭示了肺腺癌中合成致死相关信号通路的预后及治疗价值
Integrative multi-omics reveals a prognostic and therapeutic landscape of synthetic lethality-associated signatures in lung adenocarcinoma
Zerong Li, Wenmei Qiao, Bin Fan, Fang Qiu, Wei Su
Journal:iScience
IF:4.5
DOI:10.1016/j.isci.2026.117098
PMID:42597961
Published:2026-08-03
research field:肿瘤学药理学药物化学有机合成药物发现
Abstract
Lung adenocarcinoma (LUAD) exhibits considerable heterogeneity and therapeutic resistance. Here, we integrated single-cell RNA sequencing, spatial transcriptomics, and machine learning to characterize synthetic lethality (SL)-associated transcriptional activity in LUAD. We quantified SL activity across malignant epithelial cells and stratified them into high-, dominant-, and low-SL groups. High-SL cells were enriched in advanced-stage and metastatic samples and showed reduced differentiation potential. Through multiple machine learning algorithms, we identified 13 high-SL signature genes, with IFRD2 (interferon-related developmental regulator 2) among the top contributors. Experimental validation confirmed IFRD2 upregulation in high-malignancy cell lines, and IFRD2 knockdown modulated sensitivity to the PARP inhibitor niraparib. The predicted compound prostaglandin A1 exhibited selective cytotoxicity against LUAD cells and induced DNA damage, consistent with an SL-related mechanism. Our findings establish a framework for identifying SL-associated vulnerabilities and provide a resource of candidate genes and compounds for further mechanistic investigation in LUAD precision therapy.
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


